In STADA appointed the new head of Consumer HealthCare

C July 15, Oksana Pozdnyakova joined the management team STADA in the region “Russia and CIS” in the position of Vice President for OTC drugs. She will be responsible for the development of a portfolio of Consumer HealthCare products (CHC), where STADA has all the prerequisites to become the market leader.

Pozdnyakova joins Glenmark from STADA, where for two years she held the position of Vice-President and General Director for Russia. Prior to this she was head of the Russian branch of the company Medela AG.

His professional career in the pharmaceutical industry Oksana Pozdnyakova started in the marketing Department of the company SmithKline Beecham/ GlaxoSmithKline. For over 15 years held senior positions in companies Novartis Pharma and Sanofi, working in Switzerland and Russia. In 2014-2015, was Chairman of OTC Committee of the Association of international pharmaceutical manufacturers (AIPM).

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]